Low Meningococcal Vaccination Rates Among Patients With Newly Diagnosed Complement Component Deficiencies in the United States
| Autor: | Cosmina Hogea, Ami R Buikema, Patricia Novy, Gary S. Marshall, Parinaz Ghaswalla, Lindsay G S Bengtson, Tim Bancroft, Eleena Koep |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Microbiology (medical)
medicine.medical_specialty Vaccines Conjugate business.industry Primary Immunodeficiency Diseases Vaccination Meningococcal Vaccines Meningococcal vaccine Newly diagnosed United States Complement (complexity) Retrospective database Meningococcal Infections Infectious Diseases Internal medicine medicine Humans business Retrospective Studies |
| Zdroj: | Clinical Infectious Diseases. 75:155-158 |
| ISSN: | 1537-6591 1058-4838 |
| DOI: | 10.1093/cid/ciab917 |
| Popis: | Meningococcal vaccination is recommended for patients with complement component deficiencies (CDs) in the United States. In this retrospective database study, only 4.6% and 2.2% of patients received MenACWY and MenB vaccination, respectively, within 3 years of CD diagnosis. Thus, meningococcal vaccination rates among patients with CDs need to be improved. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|